A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis.

BACKGROUND: MicroRNAs are non-coding RNAs that negatively regulate gene networks. Previously, we reported that systemically delivered miR-29 mimic MRG-201 reduced fibrosis in animal models, supporting the consideration of miR-29-based therapies for idiopathic pulmonary fibrosis (IPF). METHODS: We generated MRG-229, a next-generation miR-29 mimic based on MRG-201 with improved chemical stability due to additional sugar modifications and conjugation with the internalization moiety BiPPB (PDGFbetaR-specific bicyclic peptide)1. We investigated the anti-fibrotic efficacy of MRG-229 on TGF-ß1 treated human lung fibroblasts (NHLFs), human precision cut lung slices (hPCLS), and in vivo bleomycin studies; toxicology was assessed in two animal models, rats, and non-human primates. Finally, we examined miR-29b levels in a cohort of 46 and 213 patients with IPF diagnosis recruited from Yale and Nottingham Universities (Profile Cohort), respectively. FINDINGS: The peptide-conjugated MRG-229 mimic decreased expression of pro-fibrotic genes and reduced collagen production in each model. In bleomycin-treated mice, the peptide-conjugated MRG-229 mimic downregulated profibrotic gene programs at doses more than ten-fold lower than the original compound. In rats and non-human primates, the peptide-conjugated MRG-229 mimic was well tolerated at clinically relevant doses with no adverse findings observed. In human peripheral blood from IPF patients decreased miR-29 concentrations were associated with increased mortality in two cohorts potentially identified as a target population for treatment. INTERPRETATION: Collectively, our results provide support for the development of the peptide-conjugated MRG-229 mimic as a potential therapy in humans with IPF. FUNDING: This work was supported by NIH NHLBI grants UH3HL123886, R01HL127349, R01HL141852, U01HL145567.

Studies of structural effects on the half-wave potentials of mononuclear and dinuclear nickel(II) diphosphine/dithiolate complexes.

Two series of mononuclear Ni(II) complexes of the formula (PNP)Ni(dithiolate) where PNP = R2PCH2N(CH3)CH2PR2, R = Et and Ph, have been synthesized containing dithiolate ligands that vary from five- to seven-membered chelate rings. Two series of dinuclear Ni(II) complexes of the formula {[(diphosphine)Ni]2(dithiolate)}(X)2 (X = BF4 or PF6) have been synthesized in which the chelate ring size of the dithiolate and diphosphine ligands have been systematically varied. The structures of the alkylated mononuclear complex, [(PNPEt)Ni(SC2H4SMe)]OTf, and the dinuclear complex, [(dppeNi)2(SC3H6S)](BF4)2, have been determined by X-ray diffraction studies. The complexes have been studied by cyclic voltammetry to determine how the half-wave potentials of the Ni(II/I) couples vary with chelate ring size of the ligands. For the mononuclear complexes, this potential becomes more positive as the natural bite angle of the dithiolate ligand increases. However, the potentials of the Ni(II/I) couples of the dinuclear complexes do not show a dependence on the chelate ring size of the ligands. Other aspects of the reduction chemistry of these complexes have been explored.

Hydrogen oxidation and production using nickel-based molecular catalysts with positioned proton relays.

Highly efficient electrocatalysts for both hydrogen evolution and hydrogen oxidation have been designed, synthesized, and characterized. The catalysts in their resting states are air-stable, mononuclear nickel(II) complexes containing cyclic diphosphine ligands with nitrogen bases incorporated into the ligand backbone. X-ray diffraction studies have established that the cation of [Ni(P(Ph)(2)N(Ph)(2))(2)(CH(3)CN)](BF(4))(2), 6a, (where P(Ph)(2)N(Ph)(2) is 1,3,5,7-tetraphenyl-1,5-diaza-3,7-diphosphacyclooctane) is a trigonal bipyramid with bonds to four phosphorus atoms of the two bidentate diphosphine ligands and the nitrogen atom of an acetonitrile molecule. Two of the six-membered rings formed by the diphosphine ligands and Ni have boat conformations with an average Ni- - -N distance to the two pendant bases of 3.4 A. The cation of [Ni(P(Cy)(2)N(Bz)(2))(2)](BF(4))(2), 6b, (where Cy = cyclohexyl and Bz = benzyl) is a distorted square planar complex. For 6b, all four six-membered rings formed upon coordination of the diphosphine ligands to the metal are in the boat form. In this case, the average Ni- - -N distance to the pendant base is 3.3 A. Complex 6a is an electrocatalyst for hydrogen production in acidic acetonitrile solutions, and compound 6b is an electrocatalyst for hydrogen oxidation in basic acetonitrile solutions. It is demonstrated that the high catalytic rates observed with these complexes are a result of the positioning of the nitrogen base so that it plays an important role in the formation and cleavage of the H-H bond.